
Alphabet Inc (NASDAQ:GOOG) has submitted data to the FDA for a new Fitbit feature that passively monitors users' heart rhythms. The approval would allow Google to market the Fitbit as a medical device in the U.S.
Fitbit announced the Fitbit Heart Study to test how accurately the device could detect atrial fibrillation (AFib) or irregular heart rhythm.